Moreover, we found that the ACE activity level is impaired in patients with other respiratory diseases but not in the same proportion as the COVID-19 group, since the non-COVID-19 group exhibited a lower enzyme activity when compared to the post-COVID-19 group. This evidence concerns the gene ACE and respiratory system disorder.